Home 2014

Archives

FDA approves marketing of postnatal test for developmental disabilities

On Jan. 17, the U.S. Food and Drug Administration (FDA) announce that it has authorized for marketing the Affymetrix CytoScan Dx Assay, which can...

The disappearing inpatient

As hospital admissions shrink, nursing jobs are shiftingto other areas, such as outpatient offices, clinics, postacute facilities, and home care.

FDA approves first generic versions of Cymbalta

On Dec. 11, the U.S. Food and Drug Administration (FDA) approved the first generic versions of Cymbalta (duloxetine delayed-release capsules). Read more.

FDA approves new stent for treatment of pseudocysts of the pancreas

On Dec. 18, the U.S. Food and Drug Administration (FDA) allowed marketing of the AXIOS Stent and Delivery System for treating pseudocysts that form...

FDA approves new treatment for genetic coagulation disorder

On Dec. 18, the U.S. Food and Drug Administration (FDA) approved Tretten, Coagulation Factor XIII A-Subunit (Recombinant), the first recombinant product for use in...

FDA approves medical device for epilepsy

The U.S. Food and Drug Administration (FDA) has approved a device to help reduce the frequency of seizures in epilepsy patients who have not...

FDA issues safety communication for HeartStart AEDs

On Nov. 25, the U.S. Food and Drug Administration (FDA) issued a safety communication stating that certain HeartStart automated external defibrillator (AED) devices made...

Amazing apps: Space-age tools for clinicians

Health apps hold the promise of greater access to medical services, better monitoring of chronic conditions, and improved patient outcomes.

Nursing leaders hold the key to translating genomics into practice

A survey of attitudes, knowledge and genomic competency

FDA allows marketing of ‘next generation’ gene sequencing devices

On Nov. 19, the U.S. Food and Drug Administration (FDA) allowed marketing of four diagnostic devices that can be used for high throughput gene...

Study: Natural compound may block effects of methamphetamine

Researchers at the University of Missouri have found that resveratrol may block the effects of methamphetamine. Read more.

FDA approves extended-release, single-entity hydrocodone product

On Oct. 25, the U.S. Food and Drug Administration (FDA) approved Zohydro ER (hydrocodone bitartrate extended-release capsules) for the management of pain severe enough...

FDA approves Gazyva for chronic lymphocytic leukemia

On Nov. 1, the U.S. Food and Drug Administration (FDA) approved Gazyva (obinutuzumab) for use in combination with chlorambucil to treat patients with previously...

Most Recent Content